🎓 Expert Commentary / Peer Perspective
CDC and ACOG guidance call for person-centered, shared decision-making around IUD placement pain. Expert commentary aligned with this guidance identifies paracervical block as the only intervention with consistent evidence of clinical benefit, particularly in vaginally nulliparous patients.
Clinical Considerations
- Paracervical block repeatedly reduces pain and improves satisfaction in vaginally nulliparous patients, regardless of IUD type
- NSAIDs and misoprostol show no clinically meaningful pain reduction across multiple double-blind, placebo-controlled trials
- Nitrous oxide showed no benefit in a prospective randomized trial for IUD placement pain
- Anxiolytics address procedural anxiety but do not reduce insertion pain — patients should be counseled on this distinction
Practice Applications
- Integrate proactive pain conversations into every IUD counseling visit
- Consider paracervical block as the default offer for nulliparous patients
- Avoid routine pre-procedure NSAIDs or misoprostol for pain prevention
- Recognize ultrasound guidance may shorten procedure time and aid patient distraction
Related Reading
PATIENT EDUCATION
OBESITY/WEIGHT MANAGEMENT
EXERCISE/TRAINING
LEGAL MATTERS
GUIDELINES/RECOMMENDATIONS